PULMONX CORPORATION Basic Shares Outstanding (Weighted Average)
PULMONX CORPORATION (LUNG) reported Basic Shares Outstanding (Weighted Average) of 42.47 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-04
- PULMONX CORPORATION weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 42.47M shares, a 5.04% increase year-over-year.
- PULMONX CORPORATION weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 41.90M shares, a 4.86% increase year-over-year.
- PULMONX CORPORATION weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 41.41M shares, a 4.61% increase year-over-year.
- PULMONX CORPORATION weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 40.94M shares, a 4.23% increase year-over-year.
- PULMONX CORPORATION weighted average number of shares outstanding, basic for fiscal 2025 was 40.69M shares, a 4.03% increase from fiscal 2024.
- PULMONX CORPORATION weighted average number of shares outstanding, basic for fiscal 2024 was 39.11M shares, a 2.99% increase from fiscal 2023.
- PULMONX CORPORATION weighted average number of shares outstanding, basic for fiscal 2023 was 37.97M shares, a 2.37% increase from fiscal 2022.
- PULMONX CORPORATION weighted average number of shares outstanding, basic for fiscal 2022 was 37.10M shares, a 2.68% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 42.47M shares 10-Q · filed 2026-08-04 | 42.18M shares 10-Q · filed 2026-08-04 | 41.93M shares derived: average of 3 quarters · filed 2026-08-04 | 41.68M shares derived: average of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | 41.90M shares 10-Q · filed 2026-05-04 | 41.65M shares derived: average of 2 quarters · filed 2026-05-04 | 41.42M shares derived: average of 3 quarters · filed 2026-05-04 | 41.17M shares derived: average of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | 41.41M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | 41.17M shares derived: average of 2 quarters · filed 2026-03-10 | 40.93M shares derived: average of 3 quarters · filed 2026-08-04 | 40.69M shares 10-K · filed 2026-03-10 |
| 2025-09-30 | 40.94M shares 10-Q · filed 2025-11-12 | 40.68M shares derived: average of 2 quarters · filed 2026-08-04 | 40.44M shares 10-Q · filed 2025-11-12 | 40.23M shares derived: average of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | 40.43M shares 10-Q · filed 2026-08-04 | 40.19M shares 10-Q · filed 2026-08-04 | 39.99M shares derived: average of 3 quarters · filed 2026-08-04 | 39.81M shares derived: average of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | 39.95M shares 10-Q · filed 2026-05-04 | 39.77M shares derived: average of 2 quarters · filed 2026-05-04 | 39.61M shares derived: average of 3 quarters · filed 2026-05-04 | 39.44M shares derived: average of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | 39.59M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | 39.43M shares derived: average of 2 quarters · filed 2026-03-10 | 39.27M shares derived: average of 3 quarters · filed 2026-03-10 | 39.11M shares 10-K · filed 2026-03-10 |
| 2024-09-30 | 39.28M shares 10-Q · filed 2025-11-12 | 39.11M shares derived: average of 2 quarters · filed 2025-11-12 | 38.95M shares 10-Q · filed 2025-11-12 | 38.81M shares derived: average of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | 38.94M shares 10-Q · filed 2025-08-01 | 38.79M shares 10-Q · filed 2025-08-01 | 38.65M shares derived: average of 3 quarters · filed 2025-08-01 | 38.52M shares derived: average of 4 quarters · filed 2025-08-01 |
| 2024-03-31 | 38.64M shares 10-Q · filed 2025-05-02 | 38.51M shares derived: average of 2 quarters · filed 2025-05-02 | 38.38M shares derived: average of 3 quarters · filed 2025-05-02 | 38.24M shares derived: average of 4 quarters · filed 2025-05-02 |
| 2023-12-31 | 38.38M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | 38.25M shares derived: average of 2 quarters · filed 2025-02-25 | 38.11M shares derived: average of 3 quarters · filed 2025-02-25 | 37.97M shares 10-K · filed 2025-02-25 |
| 2023-09-30 | 38.12M shares 10-Q · filed 2024-11-01 | 37.97M shares derived: average of 2 quarters · filed 2024-11-01 | 37.84M shares 10-Q · filed 2024-11-01 | 37.72M shares derived: average of 4 quarters · filed 2024-11-01 |
| 2023-06-30 | 37.82M shares 10-Q · filed 2024-08-02 | 37.70M shares 10-Q · filed 2024-08-02 | 37.59M shares derived: average of 3 quarters · filed 2024-08-02 | 37.49M shares derived: average of 4 quarters · filed 2024-08-02 |
| 2023-03-31 | 37.57M shares 10-Q · filed 2024-05-03 | 37.48M shares derived: average of 2 quarters · filed 2024-05-03 | 37.38M shares derived: average of 3 quarters · filed 2024-05-03 | 37.29M shares derived: average of 4 quarters · filed 2024-05-03 |
| 2022-12-31 | 37.38M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | 37.29M shares derived: average of 2 quarters · filed 2024-02-27 | 37.19M shares derived: average of 3 quarters · filed 2024-02-27 | 37.10M shares 10-K · filed 2024-02-27 |
| 2022-09-30 | 37.19M shares 10-Q · filed 2023-11-03 | 37.10M shares derived: average of 2 quarters · filed 2023-11-03 | 37.00M shares 10-Q · filed 2023-11-03 | 36.91M shares derived: average of 4 quarters · filed 2023-11-03 |
| 2022-06-30 | 37.00M shares 10-Q · filed 2023-08-04 | 36.90M shares 10-Q · filed 2023-08-04 | 36.82M shares derived: average of 3 quarters · filed 2023-08-04 | 36.73M shares derived: average of 4 quarters · filed 2023-08-04 |
| 2022-03-31 | 36.81M shares 10-Q · filed 2023-05-08 | 36.72M shares derived: average of 2 quarters · filed 2023-05-08 | 36.63M shares derived: average of 3 quarters · filed 2023-05-08 | 36.49M shares derived: average of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | 36.64M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | 36.55M shares derived: average of 2 quarters · filed 2023-03-01 | 36.38M shares derived: average of 3 quarters · filed 2023-03-01 | 36.13M shares 10-K · filed 2023-03-01 |
| 2021-09-30 | 36.45M shares 10-Q · filed 2022-11-08 | 36.25M shares derived: average of 2 quarters · filed 2022-11-08 | 35.96M shares 10-Q · filed 2022-11-08 | 35.48M shares derived: average of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | 36.04M shares 10-Q · filed 2022-08-08 | 35.71M shares 10-Q · filed 2022-08-08 | 35.16M shares derived: average of 3 quarters · filed 2022-08-08 | 27.08M shares derived: average of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | 35.37M shares 10-Q · filed 2022-05-09 | 34.72M shares derived: average of 2 quarters · filed 2022-05-09 | 24.09M shares derived: average of 3 quarters · filed 2022-05-09 | 18.55M shares derived: average of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | 34.08M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | 18.45M shares derived: average of 2 quarters · filed 2022-03-01 | 12.94M shares derived: average of 3 quarters · filed 2022-03-01 | 10.18M shares 10-K · filed 2022-03-01 |
| 2020-09-30 | 2.81M shares 10-Q · filed 2021-11-09 | 2.38M shares derived: average of 2 quarters · filed 2021-11-09 | 2.22M shares 10-Q · filed 2021-11-09 | |
| 2020-06-30 | 1.94M shares 10-Q · filed 2021-08-10 | 1.92M shares 10-Q · filed 2021-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |